AI-Driven Pharma Market Research: Synthetic Users – with Kwame Ferreira & Rebecca Gould
Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of
AI
The Modern Patient Experience
How AI and expanded stakeholder perspectives are transforming rare disease patient journey research. Download the report to learn:
Why the ATU needs to evolve with the brand
Steve Wakefield leads the Quantitative Center of Excellence at Fulcrum Research, part of SAI. With more than 25 years of
Stability and Flexibility: Transforming your ATU tracker into an adaptive learning system
Your market changes – your ATU should change, too At Fulcrum Research, we transform your ATU into an adaptive learning
Closing the AI Perception Gap
A perspective from Fulcrum Research Group A recent article from bi.team explored an idea that immediately resonated with us: people tend to believe AI
A New Frontier: Leveraging Synthetic Users in Pharmaceutical Market Research
The pharmaceutical industry increasingly relies on sophisticated market research to understand healthcare professionals, patients, and stakeholders. However, traditional research methods—while
Adapting to the AI Era: Simulating Patient and Physician Perspectives at Scale
As recently profiled in the New York Times, the rise of AI chatbots in healthcare is fundamentally changing how patients form
Is AI at the helm of biopharma business development strategies?
Jacqueline Poot President – Strategic Consulting & Analytics BU IDEA Pharma As a moderator of this session at BIOEuropeSpring, my
Fulcrum Research Group and Synthetic Users
What it is: Synthetic Users built for pharma research: AI that behaves like real, emotional respondents. Exclusive to Fulcrum Research and SAI.